Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.

Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL.

J Natl Cancer Inst. 2008 Apr 16;100(8):563-71. doi: 10.1093/jnci/djn075. Epub 2008 Apr 8. Erratum in: J Natl Cancer Inst. 2008 May 21;100(10):754.

PMID:
18398105
[PubMed - indexed for MEDLINE]
Free Article
2.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
[PubMed - indexed for MEDLINE]
3.

A clinician's review of the WHI-related literature.

Speroff L.

Int J Fertil Womens Med. 2004 Nov-Dec;49(6):252-67. Review.

PMID:
15751264
[PubMed - indexed for MEDLINE]
4.

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.

Nelson HD.

JAMA. 2004 Apr 7;291(13):1610-20. Review.

PMID:
15069049
[PubMed - indexed for MEDLINE]
5.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
[PubMed - indexed for MEDLINE]
6.

Conjugated estrogens and breast cancer risk.

Campagnoli C, Ambroggio S, Biglia N, Sismondi P.

Gynecol Endocrinol. 1999 Dec;13 Suppl 6:13-9. Review.

PMID:
10862264
[PubMed - indexed for MEDLINE]
7.

Impact of WHI conclusions and ACOG guidelines on clinical practice.

Gass M.

Int J Fertil Womens Med. 2003 May-Jun;48(3):106-10; discussion 137-8. Review.

PMID:
12839140
[PubMed - indexed for MEDLINE]
8.

Indicators of increased breast cancer risk in humans.

Page DL, Dupont WD.

J Cell Biochem Suppl. 1992;16G:175-82. Review.

PMID:
1469898
[PubMed - indexed for MEDLINE]
9.

Breast cancer: the role of hormone therapy.

Creasman WT.

Semin Reprod Med. 2005 May;23(2):167-71. Review.

PMID:
15852202
[PubMed - indexed for MEDLINE]
10.

Pitfalls of the WHIs: Women's Health Initiative.

Mastorakos G, Sakkas EG, Xydakis AM, Creatsas G.

Ann N Y Acad Sci. 2006 Dec;1092:331-40. Review.

PMID:
17308158
[PubMed - indexed for MEDLINE]
11.

Clinical and histologic aspects of proliferative and non-proliferative benign breast disease.

Connolly JL, Schnitt SJ.

J Cell Biochem Suppl. 1993;17G:45-8. Review.

PMID:
8007708
[PubMed - indexed for MEDLINE]
12.

Lessons to be learned from animal studies on hormones and the breast.

Clarkson TB, Appt SE, Wood CE, Cline JM.

Maturitas. 2004 Sep 24;49(1):79-89. Review.

PMID:
15351099
[PubMed - indexed for MEDLINE]
13.

Postmenopausal testosterone therapy and breast cancer risk.

Somboonporn W, Davis SR.

Maturitas. 2004 Dec 10;49(4):267-75. Review.

PMID:
15531122
[PubMed - indexed for MEDLINE]
14.

Benign breast disease and breast cancer risk: potential role for antiestrogens.

Schnitt SJ.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4419s-4422s; discussion 4411s-4412s. Review.

PMID:
11916234
[PubMed - indexed for MEDLINE]
15.

Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.

Speroff L.

Maturitas. 2004 Sep 24;49(1):51-7. Review.

PMID:
15351096
[PubMed - indexed for MEDLINE]
16.

The patho-epidemiology of benign proliferative epithelial disorders of the female breast.

Cook MG, Rohan TE.

J Pathol. 1985 May;146(1):1-15. Review.

PMID:
3891937
[PubMed - indexed for MEDLINE]
17.

Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial.

Antoine C, Liebens F, Carly B, Pastijn A, Rozenberg S; Women's Health Initiative.

Hum Reprod. 2004 Mar;19(3):741-56. Epub 2004 Jan 29. Review.

PMID:
14998980
[PubMed - indexed for MEDLINE]
Free Article
18.

Women's Health Initiative results: a glass more empty than full.

Strickler RC.

Fertil Steril. 2003 Sep;80(3):488-90. Review.

PMID:
12969683
[PubMed - indexed for MEDLINE]
19.

Atypia in the assessment of breast cancer risk: implications for management.

Vogel VG.

Diagn Cytopathol. 2004 Mar;30(3):151-7. Review.

PMID:
14986294
[PubMed - indexed for MEDLINE]
20.

[Postmenopausal hormone replacement therapy and breast cancer risk: an update].

van den Brûle F, Lifrange E, Pintiaux A, Foidart JM, Gaspard U.

Rev Med Liege. 2003 Apr;58(4):254-60. Review. French.

PMID:
12868330
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk